Source: Breathe, 16 (4) 200203; 10.1183/20734735.0203-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Xuan Yao, Megat Abd Hamid, Anand Sundaralingam, Alice Evans, Roshan Karthikappallil, Tao Dong, Najib M. Rahman, Nikolaos I. Kanellakis. Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases. Breathe, 16 (4) 200203; 10.1183/20734735.0203-2020

Member's Comments

No comment yet.

Related content which might interest you: Pleural effusion in chronic kidney disease: An ongoing dilemma Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Effecs of systemic inflammation markers for determining success of talc pleurodeisis on patients with malignant pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003 Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017 Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias Year: 2006 Incidence and characteristics of pleural effusions in patients with chronic lymphocytic leukemia- A 16 year experience Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Evaluation of inflammatory mediators of pleural effusion in tuberculosis and non-tuberculosis patients Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 Pulmonary and pleural manifestations in scleroderma Source: Eur Respir J 2006; 28: Suppl. 50, 382s Year: 2006 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia Source: International Congress 2016 – Connective tissue disorders Year: 2016 Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Pleural effusion in hemodialysis patients with chronic kidney disease Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 The management of benign non-infective pleural effusions Source: Eur Respir Rev 2016; 25: 303-316 Year: 2016 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015 Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Pleural effusion in patients with IgG4-related disease: Investigated features and compared to tuberculous pleurisy Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Results of microbiologic research of lungs‘ and pleura‘s acute purulent destructive disease Source: Annual Congress 2008 - Pleuropulmonary infections; thoracic trauma Year: 2008